Beyond Beer, Tilray’s $1.67 Billion Market Play: Is This Cannabis Giant Still A Smart Buy?

Zuanic & Associates rates Tilray “Neutral,” noting long-term potential but near-term uncertainties, despite cannabis growth in Germany. Latest Ratings for TAP DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022CitigroupMaintainsBuy Nov 2021BarclaysMaintainsEqual-Weight View More Analyst Ratings for TAP View the Latest Analyst Ratings read more

Read More